Home > Insider Trading > Filing (0001209191-13-047530)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1396814	Pacira Pharmaceuticals Inc.	PCRX	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1283535	Gary Patou	C/O Mpm Asset Management 601 Gateway Blvd., Suite 350 South San Francisco CA 94080	Chief Medical Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-10-01	20,000	$1.61	20,000	No	4	M	Direct
Common Stock	Disposition	2013-10-01	20,000	$48.92	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2013-10-01	20,000	$0.00	20,000	$1.61

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
18,084		2020-09-02	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	115	Indirect	See Footnote

Footnotes

This transaction was pursuant to a 10b5-1 Plan.
Represents weighted average sales price. The shares were sold at prices ranging from $48.71 to $49.25. The Reporting Person will provide upon request, to the SEC, the Issuer or any securityholder of the Issuer, full information regarding the number of shares sold at each separate price.
Shares held by Patou Family Trust, of which the reporting person is trustee.
25% of the option shares vest on September 2, 2011 and the remaining 75% of the option shares shall vest monthly over the next 36 months. The option shares become exercisable when vested.